Cargando…

CT-based decision tree model for predicting EGFR mutation status in synchronous multiple primary lung cancers

BACKGROUND: The current study aimed to construct a computed tomography (CT)-based decision tree algorithm (DTA) model to predict the epidermal growth factor receptor (EGFR) mutation status in synchronous multiple primary lung cancers (SMPLCs). METHODS: The demographic and CT findings of 85 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yingwei, Li, Shuangjiang, Ma, Huiyun, Zhang, Wenbiao, Liu, Baocong, Xie, Chuanmiao, Li, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089846/ https://www.ncbi.nlm.nih.gov/pubmed/37065592 http://dx.doi.org/10.21037/jtd-22-1312

Ejemplares similares

Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
por: Zheng, Lie, et al.
Publicado: (2022)

Differentiating synchronous double primary lung adenocarcinomas from intrapulmonary metastasis by CT features, EGFR mutations and ALK rearrangement status
por: Han, Xiaoyu, et al.
Publicado: (2020)

Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations
por: Qu, Rirong, et al.
Publicado: (2022)

Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
por: Zhang, Guojin, et al.
Publicado: (2020)

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
por: Digumarthy, Subba R., et al.
Publicado: (2019)

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma
por: Ren, Yaoyao, et al.
Publicado: (2015)

Different EGFR gene mutations in two patients with synchronous multiple lung cancers: A case report
por: Sakai, Hiroki, et al.
Publicado: (2017)

Imaging of synchronous multiple primary lung adenocarcinoma with concomitant EGFR and KRAS mutations: a case report and review of the literature
por: Ma, Jing-Wen, et al.
Publicado: (2021)

CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas
por: Han, Xiaoyu, et al.
Publicado: (2020)

Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis
por: Zhou, Xudong, et al.
Publicado: (2016)

Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?
por: Qu, Rirong, et al.
Publicado: (2021)

Synchronous multiple primary lung cancers with shared EGFR mutation but differential imaging findings and pathological subtypes: A case report
por: Su, Lei, et al.
Publicado: (2020)

EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma
por: Chen, Quan, et al.
Publicado: (2022)

Application of CT radiomics features to predict the EGFR mutation status and therapeutic sensitivity to TKIs of advanced lung adenocarcinoma
por: Yang, Chunsheng, et al.
Publicado: (2020)

NSCLC With Synchronous EGFR Mutations in Li Fraumeni Syndrome: A Case Report
por: Marks, Jennifer A., et al.
Publicado: (2023)

PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features
por: Huang, Weicheng, et al.
Publicado: (2022)

Prognosis value of Hypoxia-inducible factor-1α expression in patients with bone and soft tissue sarcoma: a meta-analysis
por: Li, Yongjiang, et al.
Publicado: (2016)

Radiomic Signatures for Predicting Receptor Status in Breast Cancer Brain Metastases
por: Luo, Xiao, et al.
Publicado: (2022)

CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
por: Mei, Dongdong, et al.
Publicado: (2018)

Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma
por: Zhang, Baihua, et al.
Publicado: (2021)

CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma
por: Shen, Tong-xu, et al.
Publicado: (2019)

RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions
por: de Macedo, Mariana Petaccia, et al.
Publicado: (2015)

EGFR unusual mutation status in lung adenocarcinomas
por: Alarcão, Ana, et al.
Publicado: (2010)

NGS-Based ctDNA Profiling After the Resistance of Second-Line Osimertinib for Patient with EGFR-Mutated Pulmonary Adenocarcinoma
por: Li, Dan, et al.
Publicado: (2021)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC
por: Lin, Liaoyi, et al.
Publicado: (2020)

Decision trees to evaluate the risk of developing multiple sclerosis
por: Pasella, Manuela, et al.
Publicado: (2023)

Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
por: Li, Xiaofeng, et al.
Publicado: (2019)

Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients—a radiomics nomogram analysis
por: Yang, Xiaoyan, et al.
Publicado: (2021)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Application Value of PET/CT and MRI in the Diagnosis and Treatment of Patients With Synchronous Multiple Pulmonary Ground-Glass Nodules
por: Xie, Shaonan, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of heat shock protein 27 (HSP27) expression in non-small cell lung cancer: a systematic review and meta-analysis
por: Li, Shuangjiang, et al.
Publicado: (2016)

Mutation Status and Immunohistochemical Correlation of EGFR Mutations in Gastrointestinal Stromal Tumors
por: Ozkayalar, H, et al.
Publicado: (2021)

Model for predicting EGFR mutation status in lung cancer
por: Nguyen Ho, Lam, et al.
Publicado: (2019)

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs
por: Yang, Liping, et al.
Publicado: (2022)

Performance of (18)F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
por: Zhang, Min, et al.
Publicado: (2020)

Applications of Depth Minimization of Decision Trees Containing Hypotheses for Multiple-Value Decision Tables
por: Azad, Mohammad, et al.
Publicado: (2023)

Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers
por: Gilson, Pauline, et al.
Publicado: (2021)

Case report: Different mechanisms of drug resistance in a synchronous multiple primary lung cancer patient after EGFR-TKI treatment
por: Xie, Shaonan, et al.
Publicado: (2022)

Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ctuo3l24vik72aj1233rrakg8